Long-term dementia risk prediction by the LIBRA score: A 30-year follow-up of the CAIDE study.


Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
02 2020
Historique:
received: 18 04 2019
accepted: 07 11 2019
pubmed: 19 11 2019
medline: 13 11 2020
entrez: 19 11 2019
Statut: ppublish

Résumé

As no causal treatment for dementia is available yet, the focus of dementia research is slowly shifting towards prevention strategies. Therefore, this study aimed to examine the predictive accuracy of the "LIfestyle for BRAin Health" (LIBRA) score, a weighted compound score of 12 modifiable risk and protective factors, for dementia and mild cognitive impairment (MCI) in midlife and late-life, and in individuals with high or low genetic risk based on presence of the apolipoprotein (APOE) ε4 allele. The LIBRA score was calculated for participants from the Finnish Cardiovascular Risk Factors, Aging and Dementia (CAIDE) population-based study examined in midlife (n = 1024) and twice in late-life (n = 604) up to 30 years later. Diagnoses of MCI and dementia were made according to established criteria. Cox proportional hazards models were used to assess the association between LIBRA and risk of dementia and MCI in models adjusted for sex and education (age as timescale). Higher midlife LIBRA scores were related to higher risk of dementia (hazard ratio [HR] = 1.27; 95% confidence interval [CI], 1.13-1.43) and MCI (unadjusted model: HR = 1.12; 95% CI, 1.03-1.22) up to 30 years later. Higher late-life LIBRA scores were related to higher risk of MCI (HR = 1.11; 95% CI, 1.00-1.25), but not dementia (HR = 1.02; 95% CI, 0.84-1.24). Higher late-life LIBRA scores were related to higher dementia risk among apolipoprotein E (APOE) ε4 non-carriers. Findings emphasize the importance of modifiable risk and protective factors for dementia prevention.

Identifiants

pubmed: 31736136
doi: 10.1002/gps.5235
pmc: PMC7003764
doi:

Substances chimiques

Apolipoproteins E 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

195-203

Informations de copyright

© 2019 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Références

J Lab Clin Med. 1993 Apr;121(4):598-602
pubmed: 8095964
Alzheimers Dement. 2014 Sep;10(5):562-70
pubmed: 24035147
Int J Geriatr Psychiatry. 2018 Jan;33(1):167-175
pubmed: 28247500
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Int J Epidemiol. 1994 Jun;23(3):495-504
pubmed: 7960373
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Nat Rev Neurol. 2015 Jul;11(7):375-7
pubmed: 25986502
Gerontologist. 2009 Jun;49 Suppl 1:S3-11
pubmed: 19525214
J Alzheimers Dis. 2017;58(2):537-547
pubmed: 28453475
J Alzheimers Dis. 2019;70(s1):S31-S41
pubmed: 30507570
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Br J Gen Pract. 2015 Nov;65(640):567-8
pubmed: 26500299
J Intern Med. 2014 Mar;275(3):229-50
pubmed: 24605807
Int J Geriatr Psychiatry. 2020 Feb;35(2):195-203
pubmed: 31736136
Neurology. 1989 Sep;39(9):1159-65
pubmed: 2771064
PLoS One. 2015 Sep 03;10(9):e0136181
pubmed: 26334524
Psychosom Med. 1996 Mar-Apr;58(2):113-21
pubmed: 8849626
Br Med J. 1979 Nov 10;2(6199):1173-8
pubmed: 519351
Aging Ment Health. 2018 Oct;22(10):1272-1278
pubmed: 28151002
JAMA. 1995 Apr 26;273(16):1274-8
pubmed: 7646655
BMC Public Health. 2019 Jun 3;19(1):678
pubmed: 31159779
Br Med J (Clin Res Ed). 1983 Dec 17;287(6408):1840-4
pubmed: 6423038
J Alzheimers Dis. 2018;62(1):373-384
pubmed: 29439337
Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):103-12
pubmed: 22163237
Can Fam Physician. 2006 Feb;52:200-7
pubmed: 16529393
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Alzheimers Dement. 2015 Jun;11(6):718-26
pubmed: 26045020
Lancet Neurol. 2006 Sep;5(9):735-41
pubmed: 16914401
Int J Geriatr Psychiatry. 2015 Mar;30(3):234-46
pubmed: 25504093
J Alzheimers Dis. 2019;71(2):549-557
pubmed: 31424404
World Health Stat Q. 1988;41(3-4):115-40
pubmed: 3232405
BMJ. 2001 Jun 16;322(7300):1447-51
pubmed: 11408299
Neurology. 2015 Apr 7;84(14):1433-42
pubmed: 25788555
Eur J Epidemiol. 2018 Jul;33(7):645-655
pubmed: 29740780
PLoS One. 2018 Apr 19;13(4):e0196085
pubmed: 29672559
Pilot Feasibility Stud. 2015 Nov 17;1:40
pubmed: 27965818
Epidemiology. 2011 Sep;22(5):646-59
pubmed: 21705906
Obes Rev. 2011 May;12(5):e426-37
pubmed: 21348917
BMC Public Health. 2014 Jun 28;14:661
pubmed: 24972448

Auteurs

Kay Deckers (K)

Alzheimer Centrum Limburg, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.

Mariagnese Barbera (M)

Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.

Sebastian Köhler (S)

Alzheimer Centrum Limburg, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.

Tiia Ngandu (T)

Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland.
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.

Martin van Boxtel (M)

Alzheimer Centrum Limburg, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.

Minna Rusanen (M)

Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland.

Tiina Laatikainen (T)

Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland.
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Hospital District of North Karelia, Joensuu, Finland.

Frans Verhey (F)

Alzheimer Centrum Limburg, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.

Hilkka Soininen (H)

Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Neurocenter, Department of Neurology, Kuopio University Hospital, Kuopio, Finland.

Miia Kivipelto (M)

Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, United Kingdom.

Alina Solomon (A)

Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH